{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:03:16Z","timestamp":1788620596168,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013420","name":"Tsumura and Company","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11418-025-01999-z","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:51:56Z","timestamp":1770151916000},"page":"462-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Juzentaihoto modulates gut microbiota and potentiates the anti-tumor effect of anti-PD-1 antibody in an immunogenic mouse melanoma model"],"prefix":"10.1007","volume":"80","author":[{"given":"Kanata","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sekido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsue","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-ichiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Susukida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"4","key":"1999_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168(4):707\u2013723. https:\/\/doi.org\/10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"issue":"2","key":"1999_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao J, Shi LZ, Zhao H, Chen J, Xiong L, He Q et al (2016) Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to Anti-CTLA-4 therapy. Cell 167(2):397\u2013404. https:\/\/doi.org\/10.1016\/j.cell.2016.08.069","journal-title":"Cell"},{"issue":"5","key":"1999_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","volume":"33","author":"MD Hellmann","year":"2018","unstructured":"Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A et al (2018) Genomic features of response to combination immunotherapy in patients with advanced Non-Small-Cell lung cancer. Cancer Cell 33(5):843\u2013852. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.018","journal-title":"Cancer Cell"},{"issue":"2","key":"1999_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","volume":"7","author":"DS Shin","year":"2017","unstructured":"Shin DS, Zaretsky JM, Escuin-Ordinas H, Garcia-Diaz A, Hu-Lieskovan S, Kalbasi A et al (2017) Primary resistance to PD-1 Blockade mediated by JAK1\/2 mutations. Cancer Discov 7(2):188\u2013201. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1223","journal-title":"Cancer Discov"},{"issue":"9","key":"1999_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S et al (2016) Mutations associated with acquired resistance to PD-1 Blockade in melanoma. N Engl J Med 375(9):819\u2013829. https:\/\/doi.org\/10.1056\/NEJMoa1604958","journal-title":"N Engl J Med"},{"issue":"2","key":"1999_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M et al (2015) Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42(2):344\u2013355. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.010","journal-title":"Immunity"},{"issue":"2","key":"1999_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the Tumor-Immune microenvironment. Cell Host Microbe 14(2):207\u2013215. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007","journal-title":"Cell Host Microbe"},{"issue":"11","key":"1999_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, \u00d6sterreicher CH, Kluwe J, Osawa Y, Brenner DA et al (2007) TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat Med 13(11):1324\u20131332. https:\/\/doi.org\/10.1038\/nm1663","journal-title":"Nat Med"},{"issue":"3","key":"1999_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","volume":"175","author":"V Singh","year":"2018","unstructured":"Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R et al (2018) Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175(3):679\u2013694. https:\/\/doi.org\/10.1016\/j.cell.2018.09.004","journal-title":"Cell"},{"issue":"7456","key":"1999_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S et al (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97\u2013101. https:\/\/doi.org\/10.1038\/nature12347","journal-title":"Nature"},{"issue":"6264","key":"1999_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams J, Roux A, Becharef S et al (2015) Commensal bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science 350(6264):1079\u20131084. https:\/\/doi.org\/10.1126\/science.aac4255","journal-title":"Science"},{"issue":"6264","key":"1999_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C et al (2015) Anticancer immunotherapy by CTLA-4 Blockade relies on the gut microbiota. Science 350(6264):1079\u20131084. https:\/\/doi.org\/10.1126\/science.aad1329","journal-title":"Science"},{"issue":"6371","key":"1999_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut Microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236","journal-title":"Science"},{"issue":"6371","key":"1999_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML et al (2018) The commensal Microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104\u2013108. https:\/\/doi.org\/10.1126\/science.aao3290","journal-title":"Science"},{"issue":"6371","key":"1999_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R et al (2018) Gut Microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91\u201397. https:\/\/doi.org\/10.1126\/science.aan3706","journal-title":"Science"},{"issue":"6509","key":"1999_CR16","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H et al (2020) Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369(6509):1481\u20131489. https:\/\/doi.org\/10.1126\/science.abc3421","journal-title":"Science"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120238","volume":"33","author":"S Caballero","year":"2015","unstructured":"Caballero S, Pamer EG (2015) Microbiota-Mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 33:227\u2013256. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120238","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1999_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/tkm2.1367","volume":"10","author":"T Nishiuchi","year":"2023","unstructured":"Nishiuchi T, Nomura K, Suezawa Y (2023) Roles of Kampo medicine in chemotherapy-related adverse events. Traditional Kampo Med 10(2):90\u201396. https:\/\/doi.org\/10.1002\/tkm2.1367","journal-title":"Traditional Kampo Med"},{"issue":"1","key":"1999_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/tkm2.1363","volume":"10","author":"Y Motoo","year":"2023","unstructured":"Motoo Y, Silke C (2023) Significance of Kampo medicine for cancer supportive care: overview. Traditional Kampo Med 10(1):16\u201319. https:\/\/doi.org\/10.1002\/tkm2.1363","journal-title":"Traditional Kampo Med"},{"issue":"3","key":"1999_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/tkm2.1387","volume":"10","author":"S Takayama","year":"2023","unstructured":"Takayama S, Michihara S, Kimura Y, Morinaga A, Miyakawa K, Tsushima N et al (2023) Review of frequently used Kampo prescriptions: part 4, ninjin\u2019yoeito. Traditional Kampo Med 10(3):224\u2013252. https:\/\/doi.org\/10.1002\/tkm2.1387","journal-title":"Traditional Kampo Med"},{"issue":"6","key":"1999_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1248\/bpb.23.677","volume":"23","author":"Ikuo Saiki","year":"2000","unstructured":"Ikuo Saiki (2000) A Kampo medicine \u2018Juzen-taiho-to\u2019 -Prevention of malignant progression and metastasis of tumor cells and the mechanism of action-. Biol Pharm Bull 23(6):677\u2013688. https:\/\/doi.org\/10.1248\/bpb.23.677","journal-title":"Biol Pharm Bull"},{"key":"1999_CR22","doi-asserted-by":"publisher","first-page":"6054706","DOI":"10.1155\/2017\/6054706","volume":"2017","author":"S Ishikawa","year":"2017","unstructured":"Ishikawa S, Ishikawa T, Tezuka C, Asano K, Sunagawa M, Hisamitsu T (2017) Efficacy of Juzentaihoto for tumor immunotherapy in B16 melanoma metastasis model. Based Complement Alternat Med 2017:6054706. https:\/\/doi.org\/10.1155\/2017\/6054706","journal-title":"Based Complement Alternat Med"},{"key":"1999_CR23","doi-asserted-by":"publisher","first-page":"743153","DOI":"10.1093\/ecam\/nen081","volume":"2011","author":"T Matsuda","year":"2011","unstructured":"Matsuda T, Maekawa K, Asano K, Hisamitsu T (2011) Suppressive effect of Juzen-Taiho-To on lung metastasis of B16 melanoma cells in vivo. Evid Based Complement Alternat Med 2011:743153. https:\/\/doi.org\/10.1093\/ecam\/nen081","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"1999_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1349-7006.1998.tb00550.x","volume":"89","author":"Y Ohnishi","year":"1998","unstructured":"Ohnishi Y, Fujii H, Hayakawa Y, Sakukawa R, Yamaura T, Sakamoto T et al (1998) Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Jpn J Cancer Res 89(2):206\u2013213. https:\/\/doi.org\/10.1111\/j.1349-7006.1998.tb00550.x","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"1999_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/tkm2.70007","volume":"12","author":"M Endo","year":"2025","unstructured":"Endo M, Yamaguchi K, Ishii T, Nagai T, Kiyohara H (2025) Preventive effects of hochuekkito, a traditional Japanese herbal formula comprising atractylodis rhizoma, on anti-PD-1 antibody-induced intestinal mucositis through the elimination of self-reactive T cells. Traditional Kampo Med 12(2):100\u2013110. https:\/\/doi.org\/10.1002\/tkm2.70007","journal-title":"Traditional Kampo Med"},{"issue":"2","key":"1999_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/tkm2.1417","volume":"11","author":"H Yoshioka","year":"2024","unstructured":"Yoshioka H, Tominaga S, Amano F, Wu Sixun, Torimoto S, Moriishi T et al (2024) Juzentaihoto alleviates cisplatin-induced renal injury in mice. Traditional Kampo Med 11(2):147\u2013155. https:\/\/doi.org\/10.1002\/tkm2.1417","journal-title":"Traditional Kampo Med"},{"issue":"1","key":"1999_CR27","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1038\/s41598-020-62506-w","volume":"10","author":"S Fujisaka","year":"2020","unstructured":"Fujisaka S, Usui I, Nawaz A, Igarashi Y, Okabe K, Furusawa Y et al (2020) Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity. Sci Rep 10(1):5544. https:\/\/doi.org\/10.1038\/s41598-020-62506-w","journal-title":"Sci Rep"},{"key":"1999_CR28","doi-asserted-by":"publisher","first-page":"903459","DOI":"10.3389\/fimmu.2022.903459","volume":"13","author":"Z Shi","year":"2022","unstructured":"Shi Z, Takeuchi T, Nakanishi Y, Kato T, Beck K, Nagata R et al (2022) A Japanese herbal Formula, Daikenchuto, alleviates experimental colitis by reshaping microbial profiles and enhancing group 3 innate lymphoid cells. Front Immunol 13:903459. https:\/\/doi.org\/10.3389\/fimmu.2022.903459","journal-title":"Front Immunol"},{"issue":"1","key":"1999_CR29","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/s41598-019-40278-2","volume":"9","author":"K Takayama","year":"2019","unstructured":"Takayama K, Takahara C, Tabuchi N, Okamura N (2019) Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation. Sci Rep 9(1):3833. https:\/\/doi.org\/10.1038\/s41598-019-40278-2","journal-title":"Sci Rep"},{"key":"1999_CR30","doi-asserted-by":"publisher","first-page":"105981","DOI":"10.1016\/j.phrs.2021.105981","volume":"175","author":"H Yamashita","year":"2022","unstructured":"Yamashita H, Nishiyama M, Ohbuchi K, Kanno H, Tsuchiya K, Yamaguchi J et al (2022) Predicting Inchinkoto efficacy, in patients with obstructive jaundice associated with malignant tumors, through pharmacomicrobiomics. Pharmacol Res 175:105981. https:\/\/doi.org\/10.1016\/j.phrs.2021.105981","journal-title":"Pharmacol Res"},{"issue":"1","key":"1999_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/tkm2.1404","volume":"11","author":"S Watanabe","year":"2024","unstructured":"Watanabe S, Takahashi K, Suresh A, Furusawa Y, Tabuchi Y, Nishidono Y et al (2024) Goreisan-induced modulation of fecal bile acid composition and gut microbiota in mice. Traditional Kampo Med 11(1):46\u201353. https:\/\/doi.org\/10.1002\/tkm2.1404","journal-title":"Traditional Kampo Med"},{"key":"1999_CR32","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11418-025-01959-7","volume":"79","author":"N Ikarashi","year":"2025","unstructured":"Ikarashi N, Kon R, Sakai H, Hosoe T (2025) Role of the gut microbiota in the Pharmacological effects of traditional Kampo medicine and natural products. J Nat Med 79:1447\u20131454. https:\/\/doi.org\/10.1007\/s11418-025-01959-7","journal-title":"J Nat Med"},{"issue":"9","key":"1999_CR33","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1111\/cas.15050","volume":"112","author":"M Mojic","year":"2021","unstructured":"Mojic M, Shitaoka K, Ohshima C, Ucche S, Lyu F, Hamana H et al (2021) NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment. Cancer Sci 112(9):3484\u20133490. https:\/\/doi.org\/10.1111\/cas.15050","journal-title":"Cancer Sci"},{"key":"1999_CR34","doi-asserted-by":"publisher","first-page":"146856","DOI":"10.1016\/j.gene.2022.146856","volume":"846","author":"S Ishizawa","year":"2022","unstructured":"Ishizawa S, Nishi A, Kaifuchi N, Shimobori C, Nahata M, Yamada C et al (2022) Integrated analysis of effect of daisaikoto, a traditional Japanese medicine, on the metabolome and gut Microbiome in a mouse model of nonalcoholic fatty liver disease. Gene 846:146856. https:\/\/doi.org\/10.1016\/j.gene.2022.146856","journal-title":"Gene"},{"issue":"5","key":"1999_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"J Gregory Caporaso","year":"2010","unstructured":"Gregory Caporaso J, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK et al (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335\u2013336. https:\/\/doi.org\/10.1038\/nmeth.f.303","journal-title":"Nat Methods"},{"issue":"1","key":"1999_CR36","doi-asserted-by":"publisher","first-page":"e13678","DOI":"10.1111\/pai.13678","volume":"33","author":"JR Ahn","year":"2022","unstructured":"Ahn JR, Lee SH, Kim B, Hee Nam M, Kyung Ahn Y, Mee Park Y et al (2022) Ruminococcus gnavus ameliorates atopic dermatitis by enhancing Treg cell and metabolites in BALB\/c mice. Pediatr Allergy Immunol 33(1):e13678. https:\/\/doi.org\/10.1111\/pai.13678","journal-title":"Pediatr Allergy Immunol"},{"issue":"7480","key":"1999_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446\u2013450. https:\/\/doi.org\/10.1038\/nature12721","journal-title":"Nature"},{"issue":"11","key":"1999_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Kamada T, Sugiyama E, Nishinakamura H, Takeuchi Y et al (2020) The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 Blockade therapies. Nat Immunol 21(11):1346\u20131358. https:\/\/doi.org\/10.1038\/s41590-020-0769-3","journal-title":"Nat Immunol"},{"issue":"11","key":"1999_CR39","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/nm.3358","volume":"19","author":"E Kobayashi","year":"2013","unstructured":"Kobayashi E, Mizukoshi E, Kishi H, Ozawa T, Hamana H, Nagai T et al (2013) A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days. Nat Med 19(11):1542\u20131546. https:\/\/doi.org\/10.1038\/nm.3358","journal-title":"Nat Med"},{"key":"1999_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.copbio.2019.10.008","volume":"61","author":"P DeMartino","year":"2020","unstructured":"DeMartino P, Cockburn DW (2020) Resistant starch: impact on the gut Microbiome and health. Curr Opin Biotechnol 61:66\u201371. https:\/\/doi.org\/10.1016\/j.copbio.2019.10.008","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"1999_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10068-021-01027-2","volume":"31","author":"YS Hong","year":"2022","unstructured":"Hong YS, Jung DH, Chung WH, Nam YD, Kim YJ, Seo DH et al (2022) Human gut commensal bacterium Ruminococcus species FMB-CY1 completely degrades the granules of resistant starch. Food Sci Biotechnol 31(2):231\u2013241. https:\/\/doi.org\/10.1007\/s10068-021-01027-2","journal-title":"Food Sci Biotechnol"},{"issue":"8","key":"1999_CR42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/ismej.2012.4","volume":"6","author":"X Ze","year":"2012","unstructured":"Ze X, Duncan SH, Louis P, Flint HJ (2012) Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6(8):1535\u20131543. https:\/\/doi.org\/10.1038\/ismej.2012.4","journal-title":"ISME J"},{"key":"1999_CR43","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131060. https:\/\/doi.org\/10.1126\/science.1079490","journal-title":"Science"},{"issue":"8","key":"1999_CR44","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","volume":"14","author":"Y Jin","year":"2019","unstructured":"Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y et al (2019) The diversity of gut Microbiome is associated with favorable responses to Anti\u2013Programmed death 1Immunotherapy in Chinese patients with NSCLC. J Thorac Oncol 14(8):1378\u20131389. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.007","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1999_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.eururo.2023.12.014","volume":"85","author":"F Pederzoli","year":"2024","unstructured":"Pederzoli F, Riba M, Venegoni C, Marandino L, Bandini M, Alchera E et al (2024) Stool Microbiome signature associated with response to neoadjuvant pembrolizumab in patients with Muscle-invasive bladder cancer. Eur Urol 85(5):417\u2013421. https:\/\/doi.org\/10.1016\/j.eururo.2023.12.014","journal-title":"Eur Urol"},{"issue":"16","key":"1999_CR46","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.3390\/cancers13163987","volume":"13","author":"N Jing","year":"2021","unstructured":"Jing N, Wang L, Zhuang H, Jiang G, Liu Z (2021) Ultrafine jujube powder enhances the infiltration of immune cells during anti-pd-l1 treatment against murine colon adenocarcinoma. Cancers (Basel) 13(16):3987. https:\/\/doi.org\/10.3390\/cancers13163987","journal-title":"Cancers (Basel)"},{"issue":"7","key":"1999_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","volume":"39","author":"P Georgiev","year":"2019","unstructured":"Georgiev P, Charbonnier LM, Chatila TA (2019) Regulatory T cells: the many faces of Foxp3. J Clin Immunol 39(7):623\u2013640. https:\/\/doi.org\/10.1007\/s10875-019-00684-7","journal-title":"J Clin Immunol"},{"issue":"6","key":"1999_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression \u2014 implications for anticancer therapy. Nat Rev Clin Oncol 16(6):356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1999_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","volume":"21","author":"S Kumagai","year":"2024","unstructured":"Kumagai S, Itahashi K, Nishikawa H (2024) Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat Rev Clin Oncol 21(5):337\u2013353. https:\/\/doi.org\/10.1038\/s41571-024-00870-6","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"1999_CR50","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H (2019) Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci 110(7):2080\u20132089. https:\/\/doi.org\/10.1111\/cas.14069","journal-title":"Cancer Sci"},{"issue":"20","key":"1999_CR51","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y et al (2019) PD-1\u2009+\u2009regulatory T cells amplified by PD-1 Blockade promote hyperprogression of cancer. Proc Natl Acad Sci USA 116(20):9999\u201310008. https:\/\/doi.org\/10.1073\/pnas.1822001116","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1999_CR52","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3892\/ijo.2015.3208","volume":"47","author":"N Takeno","year":"2015","unstructured":"Takeno N, Inujima A, Shinohara K, Yamada M, Shibahara N, Sakurai H, Saiki I, Koizumi K (2015) Immune adjuvant effect of Juzentaihoto, a Japanese traditional herbal medicine, on tumor vaccine therapy in a mouse model. Int J Oncol 47(6):2115\u20132122. https:\/\/doi.org\/10.3892\/ijo.2015.3208","journal-title":"Int J Oncol"},{"issue":"3","key":"1999_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tibtech.2016.09.010","volume":"35","author":"S Friedensohn","year":"2017","unstructured":"Friedensohn S, Khan TA, Reddy ST (2017) Advanced methodologies in High-Throughput sequencing of immune repertoires. Trends Biotechnol 35(3):203\u2013214. https:\/\/doi.org\/10.1016\/j.tibtech.2016.09.010","journal-title":"Trends Biotechnol"},{"issue":"1","key":"1999_CR54","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12140","volume":"257","author":"C Linnemann","year":"2014","unstructured":"Linnemann C, Mezzadra R, Schumacher TNM (2014) TCR repertoires of intratumoral T-cell subsets. Immunol Rev 257(1):72\u201382. https:\/\/doi.org\/10.1111\/imr.12140","journal-title":"Immunol Rev"},{"issue":"1","key":"1999_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13046-022-02566-0","volume":"41","author":"N Porciello","year":"2022","unstructured":"Porciello N, Franzese O, D\u2019Ambrosio L, Palermo B, Nistic\u00f2 P (2022) T-cell repertoire diversity: friend or foe for protective antitumor response? J Exp Clin Cancer Res 41(1):356. https:\/\/doi.org\/10.1186\/s13046-022-02566-0","journal-title":"J Exp Clin Cancer Res"},{"key":"1999_CR56","doi-asserted-by":"publisher","unstructured":"Chiffelle J, Genolet R, As Perez M, Coukos G, Zoete V, Harari A (2020) T-cell repertoire analysis and metrics of diversity and clonality. Curr Opin Biotechnol 284\u2013295. https:\/\/doi.org\/10.1016\/j.copbio.2020.07.010","DOI":"10.1016\/j.copbio.2020.07.010"},{"issue":"1","key":"1999_CR57","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41598-018-19548-y","volume":"8","author":"A Hosoi","year":"2018","unstructured":"Hosoi A, Takeda K, Nagaoka K, Iino T, Matsushita H, Ueha S et al (2018) Increased diversity with reduced diversity evenness of tumor infiltrating T-cells for the successful cancer immunotherapy. Sci Rep 8(1):1058. https:\/\/doi.org\/10.1038\/s41598-018-19548-y","journal-title":"Sci Rep"},{"issue":"4","key":"1999_CR58","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, Horak CE, Weinhold N, Chan TA (2017) Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171(4):934\u2013949. https:\/\/doi.org\/10.1016\/j.cell.2017.09.028","journal-title":"Cell"},{"issue":"7528","key":"1999_CR59","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L et al (2014) PD-1 Blockade induces responses by inhibiting adaptive immune resistance. Nature 515(7528):568\u2013571. https:\/\/doi.org\/10.1038\/nature13954","journal-title":"Nature"},{"issue":"4","key":"1999_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nm.4051","volume":"22","author":"A Gros","year":"2016","unstructured":"Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S et al (2016) Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med 22(4):433\u2013438. https:\/\/doi.org\/10.1038\/nm.4051","journal-title":"Nat Med"},{"issue":"9","key":"1999_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1158\/2326-6066.CIR-16-0001","volume":"4","author":"A Pasetto","year":"2016","unstructured":"Pasetto A, Gros A, Robbins PF, Deniger DC, Prickett TD, Matus-Nicodemos R et al (2016) Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor. Cancer Immunol Res 4(9):734\u2013743. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0001","journal-title":"Cancer Immunol Res"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01999-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-025-01999-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01999-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:27:46Z","timestamp":1773383266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-025-01999-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s11418-025-01999-z","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was partly conducted with a research fund from Tsumura & Co. K.O., M.N., K.K, and R.T. are employees of Tsumura & Co. Other authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Studies involving animal subjects: The animal study was approved by The Committee for the Care and Use of Laboratory Animals of University of Toyama. The study was conducted in accordance with the local legislation and institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}